You just read:

TCR2 Therapeutics Presents Preclinical Data on its Lead Solid Tumor and Blood Cancer Programs at the American Association for Cancer Research (AACR) Annual Meeting

News provided by

TCR2 Therapeutics

Mar 28, 2019, 07:00 ET